HLA class I antigen loss, tumor immune escape and immune selection
- 4 September 2002
- Vol. 20, A40-A45
- https://doi.org/10.1016/s0264-410x(02)00386-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cancer Immunotherapy With Peptide-Based Vaccines: What Have We Achieved? Where Are We Going?JNCI Journal of the National Cancer Institute, 2002
- Genomics and cancerCurrent Opinion in Oncology, 2002
- HLA class I antigen cell surface expression is preserved on acute myeloid leukemia blasts at diagnosis and at relapseLeukemia, 2001
- Antigen-processing machinery breakdown and tumor growthImmunology Today, 2000
- The HLA crossroad in tumor immunologyHuman Immunology, 2000
- Optimism after much pessimism: what next?Current Opinion in Immunology, 1999
- Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional SignificancePublished by Elsevier ,1999
- TAP off - tumors onImmunology Today, 1997
- Cancer vaccines based on the identification of genes encoding cancer regression antigensImmunology Today, 1997
- Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA.Journal of Clinical Investigation, 1993